>Nタンパク/N抗体の話はみんな認識
どうせin vitroだろpgrって反応には、ならなかったですか?
私の目から見れば、
in vivo (SARS-1 in mouse)
in vivo (covid-19当初からの観察)
in the world (2021年7月インドネシア)
in vitro (私のSciRep)
in the world(中国の白肺)
in vivo 再感染←今ココ
全年齢層の50%がマスクを着用すると、コロナウイルス感染数を約40%、死亡数を約25%減らせることがわかったという記事。
Consistent mask use and SARS‐CoV‐2 epidemiology: a simulation modelling study in @theMJAhttps://mja.com.au/journal/2023/219/2/consistent-mask-use-and-sars-cov-2-epidemiology-simulation-modelling-study…
Reinfection with COVID-19 led to a greater risk of developing asthma, COPD, lung diseases, and lung cancer compared to those with a single infection.
Additionally, most risks of respiratory outcomes were increased before the availability of COVID-19 vaccination. 3/
Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID
We may have 2 subtypes of #LongCovid/ PASC!
"The overwhelming disease burden attributable to PASC worldwide6 demands that serious attention must be paid both to its accurate diagnosis as well as…
Our paper on persistent SARS-CoV-2 infections (PIs) is now published in @Nature!
Some key findings:
- PIs are much more common than we thought
- PIs are associated with higher odds of long COVID
- Reinfections with genetically similar viruses are rare
https://nature.com/articles/s41586-024-07029-4…